Assessing potential health risks of vaping e-liquid.
Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche
Plus, news about Seres Therapeutics, Nestlé Health Science, Pfizer, Evotec and Relay Therapeutics: FDA lifts partial hold on Stoke Therapeutics’ Dravet syndrome drug: … Sign